Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...
Annual breast cancer cases are estimated to rise by a third worldwide from 2023 to 2050, according to new research published in The Lancet Oncology.